Menu

Skip to content
  • About

Syn-Org-Chemist

Just another WordPress.com weblog

05.22.13
by drumesh

New class of drug targets skin cancer

New class of drug targets skin cancer.

Standard | Posted in Medicinal Chemistry | 0 comments
05.19.13
by drumesh

Discovery of new hormone opens doors to new type 2 diabetes treatments

Discovery of new hormone opens doors to new type 2 diabetes treatments.

Standard | Posted in Medicinal Chemistry | 0 comments
05.18.13
by drumesh

New delivery for cancer drugs

New delivery for cancer drugs.

Standard | Posted in Uncategorized | 0 comments
05.17.13
by drumesh

Whole walnuts and their extracted oil improve cardiovascular disease risk

Whole walnuts and their extracted oil improve cardiovascular disease risk.

Standard | Posted in Medicinal Chemistry | 0 comments
05.16.13
by drumesh

Gene offers clues to new treatments for a harmful blood clotting disorder

Gene offers clues to new treatments for a harmful blood clotting disorder.

Standard | Posted in Medicinal Chemistry | 0 comments
05.16.13
by drumesh

FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol

FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol.

Standard | Posted in Medicinal Chemistry | 1 Comment
05.15.13
by drumesh

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients.

Standard | Posted in Uncategorized | 0 comments

Post navigation

← Older posts

Blog Stats

  • 2,537 hits

Facebook

search

On Bloggers.com

Med-Chemist - Find me on Bloggers.com

  • drumesh

Disclaimer

  • About
Blog at WordPress.com. Theme: Newsworthy by WPThemes.co.nz.
Syn-Org-Chemist
Blog at WordPress.com. Theme: Newsworthy.
Follow

Get every new post delivered to your Inbox.

Join 169 other followers

Powered by WordPress.com
Cancel